Trimethylamine n-Oxide (TMAO) Modulates the Expression of Cardiovascular Disease-Related microRNAs and Their Targets
- PMID: 34681805
- PMCID: PMC8539082
- DOI: 10.3390/ijms222011145
Trimethylamine n-Oxide (TMAO) Modulates the Expression of Cardiovascular Disease-Related microRNAs and Their Targets
Abstract
Diet is a well-known risk factor of cardiovascular diseases (CVDs). Some microRNAs (miRNAs) have been described to regulate molecular pathways related to CVDs. Diet can modulate miRNAs and their target genes. Choline, betaine, and l-carnitine, nutrients found in animal products, are metabolized into trimethylamine n-oxide (TMAO), which has been associated with CVD risk. The aim of this study was to investigate TMAO regulation of CVD-related miRNAs and their target genes in cellular models of liver and macrophages. We treated HEPG-2, THP-1, mouse liver organoids, and primary human macrophages with 6 µM TMAO at different timepoints (4, 8, and 24 h for HEPG-2 and mouse liver organoids, 12 and 24 h for THP-1, and 12 h for primary human macrophages) and analyzed the expression of a selected panel of CVD-related miRNAs and their target genes and proteins by real-time PCR and Western blot, respectively. HEPG-2 cells were transfected with anti-miR-30c and syn-miR-30c. TMAO increased the expression of miR-21-5p and miR-30c-5p. PER2, a target gene of both, decreased its expression with TMAO in HEPG-2 and mice liver organoids but increased its mRNA expression with syn-miR-30c. We concluded that TMAO modulates the expression of miRNAs related to CVDs, and that such modulation affects their target genes.
Keywords: TMAO; atherosclerosis; cardiovascular disease; epigenetics; miRNAs; nutrition; target genes.
Conflict of interest statement
The authors declare no conflict of interest. The funders had no role in the design of the study; in the collection, analyses, or interpretation of data; in the writing of the manuscript, or in the decision to publish the results.
Figures





Similar articles
-
Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model.Biochem Genet. 2025 Apr;63(2):1298-1309. doi: 10.1007/s10528-024-10754-0. Epub 2024 Mar 27. Biochem Genet. 2025. PMID: 38536569
-
TMAO Upregulates Members of the miR-17/92 Cluster and Impacts Targets Associated with Atherosclerosis.Int J Mol Sci. 2022 Oct 11;23(20):12107. doi: 10.3390/ijms232012107. Int J Mol Sci. 2022. PMID: 36292963 Free PMC article.
-
Trimethylamine N-Oxide (TMAO), Diet and Cardiovascular Disease.Curr Atheroscler Rep. 2021 Feb 17;23(4):12. doi: 10.1007/s11883-021-00910-x. Curr Atheroscler Rep. 2021. PMID: 33594574 Review.
-
L-Carnitine intake and high trimethylamine N-oxide plasma levels correlate with low aortic lesions in ApoE(-/-) transgenic mice expressing CETP.Atherosclerosis. 2016 Jan;244:29-37. doi: 10.1016/j.atherosclerosis.2015.10.108. Epub 2015 Nov 2. Atherosclerosis. 2016. PMID: 26584136
-
Gut microbiota-derived trimethylamine-N-oxide: A bridge between dietary fatty acid and cardiovascular disease?Food Res Int. 2020 Dec;138(Pt B):109812. doi: 10.1016/j.foodres.2020.109812. Epub 2020 Oct 21. Food Res Int. 2020. PMID: 33288187 Review.
Cited by
-
Trimethylamine-N-oxide, a New Risk Factor for Non-alcoholic Fatty Liver Disease Changes the Expression of miRNA-34a, and miRNA-122 in the Fatty Liver Cell Model.Biochem Genet. 2025 Apr;63(2):1298-1309. doi: 10.1007/s10528-024-10754-0. Epub 2024 Mar 27. Biochem Genet. 2025. PMID: 38536569
-
The Interplay Between Dietary Choline and Cardiometabolic Disorders: A Review of Current Evidence.Curr Nutr Rep. 2024 Jun;13(2):152-165. doi: 10.1007/s13668-024-00521-3. Epub 2024 Mar 1. Curr Nutr Rep. 2024. PMID: 38427291 Free PMC article. Review.
-
Gut microbiota induced epigenetic modifications in the non-alcoholic fatty liver disease pathogenesis.Eng Life Sci. 2023 Jun 2;24(5):2300016. doi: 10.1002/elsc.202300016. eCollection 2024 May. Eng Life Sci. 2023. PMID: 38708414 Free PMC article. Review.
-
The roles of trimethylamine-N-oxide in atherosclerosis and its potential therapeutic aspect: A literature review.Biomol Biomed. 2023 Nov 3;23(6):936-948. doi: 10.17305/bb.2023.8893. Biomol Biomed. 2023. PMID: 37337893 Free PMC article. Review.
-
How can we modulate aging through nutrition and physical exercise? An epigenetic approach.Aging (Albany NY). 2023 Apr 20;15(8):3191-3217. doi: 10.18632/aging.204668. Epub 2023 Apr 20. Aging (Albany NY). 2023. PMID: 37086262 Free PMC article. Review.
References
-
- Virani S.S., Alonso A., Benjamin E.J., Bittencourt M.S., Callaway C.W., Carson A.P., Chamberlain A.M., Chang A.R., Cheng S., Delling F.N., et al. Heart Disease and Stroke Statistics—2020 Update: A Report From the American Heart Association. Circulation. 2020;141:e139–e596. doi: 10.1161/CIR.0000000000000757. - DOI - PubMed
-
- Eurostat Cardiovascular Diseases Statistics. [(accessed on 5 May 2021)]. Available online: https://ec.europa.eu/eurostat/statistics-explained/index.php/Cardiovascu....
-
- Escaño-Marín R., Pérez-Belmonte L.M., Rodríguez de la Cruz E., Gómez-Doblas J.J., de Teresa-Galván E., Jiménez-Navarro M. Cardiovascular Disease and Gross Domestic Product in Spain: Correlation Analysis by Autonomous Communities. Rev. Esp. Cardiol. 2017;70:210–212. doi: 10.1016/j.recesp.2016.07.023. - DOI - PubMed
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous